Axis Direct
We expect Gross Margins to be impacted due to an increase in revenue share from non-regulated markets and an increase in raw material prices going onwards. Hence, we recommend a HOLD rating on the stock with a target price of INR 1,670 (PE 20x for FY23EPS).
Solara Active Pharma Sciences Ltd.'s price crossed below 100Day SMA today
More from Solara Active Pharma Sciences Ltd.
Recommended